MedPath

Efficacy of Dietary Supplementation With Melatonin in Targeting Sleep Quality

Not Applicable
Not yet recruiting
Conditions
Sleep Onset Latency
Sleep Quality
Registration Number
NCT06600633
Lead Sponsor
Nutrition Institute, Slovenia
Brief Summary

single-center, randomized, cross over, double-blind, placebo controlled intervention study

Detailed Description

The single-center, randomized, cross over, double-blind, placebo controlled intervention study will include 30 subjects who will test the efficacy of three formulations with different dosages of melatonin on sleep quality parameters.

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
30
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Primary Outcome Measures
NameTimeMethod
Change in sleep onset latency (SOL) compared to placebolast 7 days of intervention

Change in sleep onset latency (SOL) compared to placebo assessed by actigraphy.

Secondary Outcome Measures
NameTimeMethod
Changed sleep quality compared to placebo14 days

Changed sleep quality compared to placebo - assessed by adapted Pittsburgh Sleep Quality Index (PSQI)

Changed sleep efficiency (SE) compared to placebolast 7 days of intervention

Changed sleep efficiency (SE) compared to placebo - assessed by actigraphy

Trial Locations

Locations (1)

CMS - Center za motnje spanja

🇸🇮

Ljubljana, Slovenia

CMS - Center za motnje spanja
🇸🇮Ljubljana, Slovenia
Barbara Gnidovec Stražišar
Principal Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.